Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

The institute’s latest multidisciplinary center–the MIT Center for Biomedical Innovation, which launched in July–is aiming to develop safer and more-efficient ways to commercialize pharmaceutical advances.

The center will include Institute researchers in science, engineering, and management, as well as scientists at Harvard Medical School. It will also draw on experts from government and industry to participate in research programs in policy, financial and risk assessment, and management. The center will be funded by government agencies, philanthropic organizations, and industry consortia.

In her keynote address at the annual meeting of the Massachusetts Biotechnology Council in May, MIT president Susan Hockfield said that the center will be a “safe harbor” where leaders in business, government, and academia can work on issues including drug safety; management of economic, financial, and regulatory risk; and manufacturing and delivery systems.

“The current system just isn’t working well anymore,” Hockfield said. “The productivity of large pharmaceutical innovation is declining. We can’t predict properly the side effects of new compounds, and we don’t have good ways to monitor and assess them once they are in the market.”

The center will not have its own laboratories; instead, it will collaborate with existing academic and commercial laboratories and hospitals. But it will focus heavily on real-world problems, and will combine technical and management solutions. The end result, the researchers hope, will be better and less expensive health care. – By Lisa Scanlon

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me